Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.
about
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium aviumAre we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?Comparison of eight methods to detect vancomycin resistance in enterococciComparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients.Proficiency of clinical laboratories in Spain in detecting vancomycin-resistant Enterococcus spp. The Spanish VRE Study Group.Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci.Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycinRevised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels.Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci.Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci.Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.A PCR assay for identification of Enterococcus faecium.Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.Recent advances: medical microbiology.Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilutionPrevalence and detection of mixed-population enterococcal bacteremia.Unacceptable performance and the lack of reproducibility results in the report of colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus.
P2860
Q28378889-D186C27F-303E-4C12-87A1-7C0549D288B3Q31004673-D9A416AF-3F60-412A-9B21-479206A89499Q33657965-ED6D3EFC-17C9-4ADF-8FD6-87D5AF47505EQ33960216-1D63F2FF-ED38-42BD-BF47-CB520D8554C4Q33961363-F14C37CE-205A-489D-98BC-75A60FE44BD0Q34971908-51AA7814-3FC0-43F2-A9DC-890E701863F5Q36528805-DDEE848C-685A-4BBF-8DF1-14CA54F3C332Q36534013-59367E2B-E9F8-4989-9751-72F02DEB06C8Q36535597-BF8F8562-DB41-458F-B6AD-FC0831ABBAD8Q36537455-B23C9341-4943-464F-852D-AB9C598513D0Q36541276-6EFE0CE7-EF54-4F6B-B7B4-AE3FB6304A0FQ36546820-E5D85EC0-05C0-45E2-98B9-318989801B6EQ36548199-3B0430F9-401B-45E0-8721-0F2709B47FD6Q36575719-86AA24A8-3CEF-49BC-87D7-B220FF5963E5Q37064313-23F94499-DBD4-41CD-8673-E9C3A879881DQ39463064-779F1A13-86CA-4EB4-936A-C41A1C5434C6Q40251093-8370A94D-71B6-4F2E-B91C-BA3A6C2EE4BEQ41878339-929063EA-8147-4886-B8BB-17CD1BED63C8Q42432319-644E6790-D61D-4402-8879-B3E3B783E64EQ42735545-2C3658E6-AC2F-4C06-AD4B-AF14C616E99EQ42742142-4CD3802E-9456-4227-9330-D0D79E53BEC9
P2860
Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Ability of commercial and refe ...... cin resistance in enterococci.
@ast
Ability of commercial and refe ...... cin resistance in enterococci.
@en
type
label
Ability of commercial and refe ...... cin resistance in enterococci.
@ast
Ability of commercial and refe ...... cin resistance in enterococci.
@en
prefLabel
Ability of commercial and refe ...... cin resistance in enterococci.
@ast
Ability of commercial and refe ...... cin resistance in enterococci.
@en
P2093
P2860
P1476
Ability of commercial and refe ...... cin resistance in enterococci.
@en
P2093
Stocker SA
Swenson JM
Tenover FC
P2860
P304
P407
P577
1995-06-01T00:00:00Z